NRX — Nurexone Biologic Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Nurexone Biologic, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.007	0.001	2.46	0.541	0.7
Net Total Receivables	0.007	0.008	0.052	0.098	0.127
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.014	1.69	2.69	1.98	1.63
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	0.102	0.188	0.807
Total Assets	0.014	1.69	2.79	2.17	2.44
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.079	1.88	0.583	1.91	0.398
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.079	1.88	0.698	1.98	0.68
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.065	-0.197	2.1	0.189	1.76
Total Liabilities & Shareholders' Equity	0.014	1.69	2.79	2.17	2.44
Total Common Shares Outstanding